vimarsana.com
Home
Live Updates
ImmuPharma signs 12-month deal with Orano for use of peptide
ImmuPharma signs 12-month deal with Orano for use of peptide
ImmuPharma signs 12-month deal with Orano for use of peptide tech
ImmuPharma PLC on Monday said it has signed an initial collaboration agreement with Orano SA for its peptide technology.
The London-based drug discovery and development company said Orano has paid a... | March 6, 2023
Related Keywords
Chatillon ,
France General ,
France ,
London ,
City Of ,
United Kingdom ,
Harvey Dorset ,
Tim Mccarthy ,
Alliance News Ltd ,
Alliance News ,
Cancer Research Centre Of Lyon ,
Immupharma Biotech ,
Cancer Research Centre ,
Executive Officer Tim Mccarthy ,
All Rights ,
Immupharma Plc Stock Exchange ,
News ,
Information ,
Press Release ,
Immupharma ,
Lc ,
N ,
Monday ,
Aid ,
It ,
Gas ,
Igned ,
Nitial ,
Collaboration ,
Agreement ,
Ith ,
Erano ,
Or ,
Its ,
Peptide ,
Drug ,
Discovery ,
End ,
Development ,
Company ,
Aid Imm Gb0033711010 ,